Correction to: A phase II study of post‑transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA‑matched related/unrelated allogeneic hematopoietic stem cell transplantation

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Hematopoietic Stem ◽

Post Transplant ◽

Gvhd Prophylaxis

A phase II study of post-transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA-matched related/unrelated allogeneic hematopoietic stem cell transplantation

International Journal of Hematology ◽

10.1007/s12185-021-03228-1 ◽

2021 ◽

Author(s):

Hirohisa Nakamae ◽

Takahiko Nakane ◽

Hiroshi Okamura ◽

Hideo Koh ◽

Yasuhiro Nakashima ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Hematopoietic Stem ◽

Post Transplant ◽

Gvhd Prophylaxis

GVHD Prophylaxis with Short Course MTX and Tacrolimus in HLA-Haploidentical Hematopoietic Stem Cell Transplantation Using Post-Transplant High Dose Cyclophosphamide

10.1016/j.bbmt.2015.11.885 ◽

2016 ◽

Vol 22 (3) ◽

pp. S374 ◽

Cited By ~ 2

Author(s):

Kinya Ohata ◽

Go Aoki ◽

Hiroyuki Takamatsu ◽

Ken Ishiyama ◽

Yukio Kondo ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

High Dose ◽

Hematopoietic Stem ◽

Post Transplant ◽

Short Course ◽

Gvhd Prophylaxis

High-dose thiotepa and hematopoietic stem cell transplantation in pediatric malignant mesenchymal tumors: a phase II study

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1702573 ◽

2000 ◽

Vol 26 (6) ◽

pp. 627-632 ◽

Cited By ~ 16

Author(s):

L Lafay-Cousin ◽

O Hartmann ◽

P Plouvier ◽

F Méchinaud ◽

P Boutard ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Phase Ii ◽

Phase Ii Study ◽

High Dose ◽

Mesenchymal Tumors ◽

Results of a Phase II Study of Propylene Glycol (PG)-Free, Captisol-Enabled Melphalan Conditioning for Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Multiple Myeloma (MM)

10.1016/j.bbmt.2014.11.190 ◽

2015 ◽

Vol 21 (2) ◽

pp. S138 ◽

Cited By ~ 1

Author(s):

Parameswaran N. Hari ◽

Omar Ajitawi ◽

Carlos Arce-Lara ◽

Rajneesh Nath ◽

Natalie Callander ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Propylene Glycol ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Phase Ii ◽

Phase Ii Study ◽

A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Stem Cell Transplantation

10.1016/j.bbmt.2014.11.516 ◽

2015 ◽

Vol 21 (2) ◽

pp. S324 ◽

Cited By ~ 1

Author(s):

Sally Arai ◽

Joseph Pidala ◽

Iskra Pusic ◽

Xiaoyu Chai ◽

Samantha Jaglowski ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Hematopoietic Stem ◽

Randomized Phase Ii

Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1701395 ◽

1998 ◽

Vol 22 (6) ◽

pp. 535-540 ◽

Cited By ~ 42

Author(s):

N Lucidarme ◽

D Valteau-Couanet ◽

O Oberlin ◽

D Couanet ◽

C Kalifa ◽

...

Keyword(s):

Stem Cell ◽

Solid Tumors ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Phase Ii ◽

Phase Ii Study ◽

High Dose ◽

Rodriguez R, Nakamura R, Palmer JM, et al. A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens. Blood. 2010;115(5):1098–1105.

Blood ◽

10.1182/blood-2010-03-276097 ◽

2010 ◽

Vol 115 (21) ◽

pp. 4318-4318

Keyword(s):

Stem Cell ◽

Pilot Study ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Phase Ii ◽

Hematopoietic Stem ◽

Gvhd Prophylaxis ◽

Conditioning Regimens

A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1705331 ◽

2006 ◽

Vol 37 (8) ◽

pp. 757-762 ◽

Cited By ~ 18

Author(s):

S Elad ◽

A Ackerstein ◽

M Bitan ◽

M Y Shapira ◽

I Resnick ◽

...

Keyword(s):

Stem Cell ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Double Blind ◽

Hematopoietic Stem ◽

Safety And Efficacy

Phase II study of dose-modified busulfan by real-time targeting in allogeneic hematopoietic stem cell transplantation for myeloid malignancy

Cancer Science ◽

10.1111/j.1349-7006.2012.02342.x ◽

2012 ◽

Vol 103 (9) ◽

pp. 1688-1694 ◽

Cited By ~ 7

Author(s):

Yachiyo Kuwatsuka ◽

Akio Kohno ◽

Seitaro Terakura ◽

Shigeki Saito ◽

Kazuyuki Shimada ◽

...

Keyword(s):

Stem Cell ◽

Real Time ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Hematopoietic Stem ◽

Myeloid Malignancy

Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America

10.1016/j.bbmt.2012.11.067 ◽

2013 ◽

Vol 19 (2) ◽

pp. S132 ◽

Cited By ~ 5

Author(s):

Michael Lill ◽

Luciano J. Costa ◽

Rosa F. Yeh ◽

Stephen Lim ◽

Robert Stuart ◽

...

Keyword(s):

Stem Cell ◽

North America ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Phase Ii ◽

Dose Adjustment ◽

Phase Ii Study ◽